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ichael W. Rampling, MD,¶ Stephanie Bayne, BS,‡ Carl Harries, BS,* Simon J. Davidson, BS,§
nselm Uebing, MD,* Arif Anis Khan, MD,* Swee Thein, MD,# J. Simon R. Gibbs, MD,**
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OBJECTIVES This study sought to determine the relationship between blood viscosity and iron deficiency
and their impact on symptoms and exercise function in adults with cyanotic congenital heart
disease.
BACKGROUND Iron deficiency is believed to raise whole blood viscosity in cyanotic congenital heart disease,
although available data are inconsistent.
METHODS Thirty-nine cyanotic adults were prospectively assessed for iron deficiency (transferrin
saturation 5%), hyperviscosity symptoms, and exercise capacity. Same-day measurement of
whole blood viscosity and hematocrit (Hct) adjusted viscosity (cells resuspended in autologous
plasma to Hct of 45%) was performed at shear rates ranging from 0.277 s1 to 128.5 s1.
RESULTS Viscosity did not differ between patients with iron deficiency (n 14) and those without (n 25).
Whole blood viscosity correlated with Hct (r  0.63, p  0.001 at low shear and r  0.84, p 
0.001 at high shear) but not with red blood cell size or iron indices. Hyperviscosity symptoms
were independent of iron indices but directly correlated with increased Hct-adjusted viscosity
(r 0.41, p 0.01). Exercise capacity did not differ in iron-deficient patients. However, peak
oxygen consumption was higher in those with Hct  65% (12.6  3.4 ml/kg/m2 vs. 9.8 
2.6 ml/kg/m2, mean  SD, p  0.036) despite higher whole blood viscosity in these same
individuals (p  0.01 for all shear rates).
CONCLUSIONS Iron deficiency is common in cyanotic adults but does not alter viscosity. Hyperviscosity
symptoms are associated with a higher Hct-adjusted viscosity independent of cell size or iron
stores. Higher Hct is associated with better exercise capacity. Further work to understand the
origin of hyperviscosity symptoms is warranted. (J Am Coll Cardiol 2006;48:356–65)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.03.040© 2006 by the American College of Cardiology Foundation
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increased whole blood viscosity in adults with cyanotic con-
enital heart disease is an unavoidable result of secondary
rythropoiesis. Little is known about the role of nonerythro-
ytotic factors in the genesis of hyperviscosity. Improved
nderstanding of the determinants of blood viscosity in
yanotic congenital heart disease is of substantial clinical
mportance.
Data showing that iron deficiency and microcytosis in-
rease whole blood viscosity are inconsistent. This relation-
hip, based on red blood cell (RBC) studies from the 1970s
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ollege Hospital; and **Hammersmith Hospital, London, England. This study was
unded by a grant from the Royal Brompton Hospital Clinical Research Committee.
alary support for Dr. Broberg was provided by the Waring Trust, as well as an
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ave received support from the British Heart Foundation. Portions of this data were
resented orally at the American College of Cardiology Scientific Sessions, March
005, in Orlando, Florida.s
Manuscript received December 8, 2005; revised manuscript received February 24,
006, accepted March 16, 2006.nd 1980s (1,2), has been shown in animals (3), polycythe-
ic adults (4), iron-deficient children (5), and cyanotic
hildren (6), although never in cyanotic adults. In contrast,
ore recent research showed viscosity to be independent of
ean corpuscular volume (MCV) in mammals (7), polycy-
hemic adults (8–10), and iron-deficient adults, in whom
BC filtration resistance was in fact lower (11). Such
onflicting results may in part be explained by the hetero-
eneity of subjects and methodology. Viscosity of whole
lood varies according to shear rate (Fig. 1). Moreover, iron
eficiency per se can also cause hyperviscosity-like symp-
oms such as headache, paresthesias, irritability, and exercise
ntolerance (12), adding complexity to the clinical care of
yanotic patients.
Iron deficiency is a spectrum that in its extreme will
ufficiently limit production of hemoglobin (Hb). Lower Hb
nd hematocrit (Hct) result in lower viscosity and systemic
xygen transport (13,14). Because Hct is the strongest deter-
inant of whole blood viscosity (5,15), it is logical to hypoth-
size that lower viscosity rather than higher viscosity would
esult from iron deficiency in cyanotic congenital heart disease.
o test this hypothesis, we quantified whole blood viscosity,
ron indices, hyperviscosity symptoms, and exercise capacity
pecifically in adults with cyanotic congenital heart disease.
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atients. Consecutive patients (age 16 years) with cya-
otic congenital heart disease (transcutaneous oxygen satu-
ation 92% at rest or 87% with exertion) were prospec-
ively enrolled from a single tertiary care facility. Patients
ith decompensated congestive heart failure, acute hemop-
ysis, endocarditis, or recent surgery were excluded. The
tudy was approved by the institutional ethics review com-
ittee, and all patients gave written consent before partic-
pation. For patients with Down syndrome or other forms of
evelopmental delay, parental consent was obtained. All
ests were performed within a 24-h period.
ssessment of symptoms and cyanosis. A thorough med-
cal history was obtained and included details of hemoptysis
r other bleeding, therapeutic phlebotomy, menses, diet,
nd use of any iron supplementation. Patients were asked in
imple language about 12 common symptoms of hypervis-
osity adapted from Perloff et al. (16). These included
eadache, faintness/dizziness, visual disturbances, fatigue,
uscle aches, joint aches, paresthesias, easy bruising, epi-
taxis, gingival bleeding, gout, and poor mental function.
atients were asked to give each symptom a 0 to 3 rank (0
eing nonexistent and 3 being severe and debilitating).
ecause symptoms often vary depending on coexisting
llness (such as common colds), medication use (e.g., allo-
urinol), or weather, patients were specifically asked to score
ymptoms based on their current clinical state. The sum of
Abbreviations and Acronyms
Hb  hemoglobin
Hct  hematocrit
MCH  mean corpuscular hemoglobin
MCHC  mean corpuscular hemoglobin concentration
MCV  mean corpuscular volume
RBC  red blood cell
Tsat  transferrin saturation
VO2  oxygen consumption
VSD  ventricular septal defect
igure 1. The inverse relationship between viscosity and shear rate is sho
v2  v1) is the difference in velocity between one flow layer and its adjac
s inversely proportional to shear rate. Thus, toward the wall of the vessel t
ess resistance). In contrast, toward the center of flow the difference in veloci
ogarithmically higher (also see Fig. 2C).he ranks gave a total viscosity symptom score (0 to 36
cale).
Oxygen saturation was measured in a seated position after
minimum of 5 min of rest using a standard transcutaneous
ulse oximeter at the finger. Saturation was measured in the
oe of any patient suspected of having differential distal
yanosis, and this saturation was used for subsequent analysis.
aboratory tests. Hematologic measurements included Hb
oncentration, packed cell volume, MCV, mean corpuscular
emoglobin (MCH), and mean corpuscular hemoglobin con-
entration (MCHC) as well as RBC, leukocyte, platelet, and
eticulocyte counts (laser-based counter, Advia 120, Bayer,
arrytown, New York). Serum tests included serum creat-
nine, urea, total bilirubin, albumin, thyroid stimulating
ormone, RBC folate, and vitamin B12 levels. Plasma
brinogen was also measured. In addition, P50 of the
xygen-Hb dissociation curve was measured on the same
ay (Hem-O-Scan, American Instrument Company, Silver
pring, Maryland). Laboratory values were reviewed by a
ematologist blinded to other data. Patients were assigned
o one of two groups: iron-deficient or iron-replete. Iron
eficiency was defined by a transferrin saturation (Tsat) 
5% (17) and a ferritin level 15 g/l.
iscosity measurement. Venous blood for viscosity assess-
ent was obtained in the early morning, preprandially, and
efore any significant exertion or planned intervention.
amples were collected into heparinized tubes (10 ml) and
nalyzed within 4 h of collection. Viscosity measurements
ere performed at 37°C using a rotational viscometer fitted
ith a bob-in-cup system (Contraves Low Shear 30, Con-
raves AG, Zurich, Switzerland), according to the recom-
endations of the International Committee for Standard-
zation in Hematology (18). Whole blood viscosity was
easured at eight predefined shear rates (0.277, 0.69, 1.74,
.39, 11.02, 27.7, 69.5, and 128.5 s1). Thereafter, Hct was
djusted to 45% (8) by the addition or subtraction of
utologous plasma (rechecked by centrifugation) and viscos-
ty at all shear rates was remeasured (Hct-adjusted viscos-
r a standard Poiseuille flow curve. Shear is defined as (v2  v1)/d, where
yer and d is the distance between layers. Viscosity, the resistance to flow,
s a larger difference in velocity (shear rate) but relatively low viscosity (i.e.,wn fo
ent la
here ity is much smaller (v6  v5)/d, hence a low shear rate, and viscosity is
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Viscosity and Iron Deficiency in Cyanosis July 18, 2006:356–65ty). Plasma viscosity was measured at shear rates of 69.5,
4.5, and 128.5 s1, and then averaged.
rythrocyte aggregation. Erythrocyte aggregation indices
ere also obtained using an erythrocyte aggregometer
Myrenne GmbH, Roetgen, Germany), a technique based
n the increased transmission of light through gaps in a
uspending medium when erythrocytes aggregate. Twenty-
ve microliters of Hct-adjusted blood (Hct 45%) were
laced between a transparent cone and plate device at 22°C
nd subjected to a high shear rate to disaggregate the cells.
fter a short delay, a digital readout was obtained, either in
tasis or at a low shear rate (3 s1), which reflected
rythrocyte aggregation both in the absence of shear and in
he presence of fluid movement, respectively. The final
ggregation index represented the mean of three readings.
xercise testing. All patients were asked to perform a
-min walk test using standard guidelines (19). In addition,
apable patients performed a maximal treadmill exercise test
sing a modified Bruce protocol. Oxygen saturation during
nd after peak exercise was recorded (sites as above), in
ddition to all standard measurements including oxygen
onsumption (VO2) measured spontaneously using a respi-
atory mass spectrometer (Amis 2000, Innovision, Odense,
enmark).
tatistical analysis. Data for continuous variables are ex-
ressed as mean  standard deviation or median/
nterquartile range if the distribution was non-normal.
inary variables are expressed as frequencies (%). Compar-
sons between iron-deficient and iron-replete groups were
ade using the Student t test, Mann-Whitney U test,
isher exact test, or chi-square testing as appropriate.
orrelations were made using the Pearson or Spearman rho
oefficient. Stepwise forward bivariate and multiple regres-
ion analyses were subsequently performed using significant
nivariate correlates (p  0.05) to determine independent
redictors of viscosity (separate models for whole blood and
ct-adjusted viscosity at high and low shear were con-
tructed), total viscosity symptom score, treadmill exercise
uration, and peak VO2. Statistical analysis was done using
PSS for Windows version 11.0 (SPSS Inc., Chicago,
llinois). A p value  0.05 was considered statistically
ignificant. The risk of type I error was 0.05 for each
ndividual comparison.
ESULTS
hirty-nine patients were studied (28 women, 11 men).
natomical diagnoses were as follows: 2 patients (5%) had an
trial septal defect, 14 (36%) had a ventricular septal defect
VSD), 4 (10%) had a patent ductus arteriosus, 3 (8%) had an
trioventricular septal defect, 7 (18%) had truncus arteriosus
r aortopulmonary window, 3 (8%) had transposition of the
reat arteries plus VSD, 2 (5%) had pulmonary atresia with
SD, 2 (5%) had double-outlet right ventricle, and 2 (5%)
ad complex single ventricle anatomy. All but 2 patients had 0isenmenger physiology (increased pulmonary vascular re-
istance with reversed or bidirectional shunt).
ron deficiency. Comparative data between iron-deficient
nd iron-replete groups are shown (Table 1). Fourteen
atients (36%) were iron deficient. Potential etiologies were
ignificant hemoptysis (defined as 1 episode of at least
ne-half cup of bright red blood within the last year),
herapeutic phlebotomy within the last year, or menorrha-
ia, but none of these factors were statistically different in
requency from the iron-replete group, except when more
han one risk factor was present (Table 1). Two iron-
eficient patients were taking warfarin but had no symp-
oms suggestive of gastrointestinal bleeding. No patients
ere vegetarian.
Iron-deficient patients had a lower resting oxygen satura-
ion, lower Hb, and higher RBC count, in addition to expected
ifferences inMCV,MCH, andMCHC (Table 1). There was
o difference in spun Hct or packed cell volume, leukocyte,
latelet, or reticulocyte counts. There were no differences in
ny blood chemistries, but there was a nonsignificant trend
oward lower fibrinogen in those with iron deficiency. There
as a significant rightward shift of the oxygen-Hb dissoci-
tion curve in the iron-deficient group.
Whole blood viscosity was not different between the
ron-replete and iron-deficient groups at any shear rate
Table 2). Viscosity corrected to a Hct of 45% (Hct-
djusted viscosity) was also not different. There was no
ifference in plasma viscosity. The RBC aggregation index
t low shear was significantly lower in those with iron
eficiency.
orrelations with viscosity. Correlation coefficients for
iscosity by univariate regression are shown. There was a
ositive correlation between whole blood viscosity and Hct,
b, packed-cell volume, and RBC count at both low and
igh shear, and the strength of correlation was similar in
hose with or without iron deficiency (Fig. 2). In contrast,
CV was unrelated to whole blood viscosity at any shear
ate. There was no correlation between viscosity and MCH,
CHC, ferritin, or Tsat at any shear rate (Table 3). On
ivariate regression analyses, Hct remained the only predic-
or of whole blood viscosity at high and low shear in models
hat incorporated Hct and either Hb, packed cell volume, or
BC counts (all p  0.001). In multiple regression models
hat incorporated all 4 univariate predictors, Hct remained
he only predictor of whole blood viscosity at low shear
partial r  0.63, p  0.001) and high shear (partial r 
.84, p  0.001).
Because Hct is such a powerful determinant of viscosity,
t was essential to measure viscosity with Hct corrected to
5%. The Hct-adjusted viscosity did not correlate with
CV (Fig. 2), nor with MCH, MCHC, ferritin, or Tsat.
y regression, Hct-adjusted viscosity was related to plasma
iscosity at low shear only (r 0.38, p 0.02), whereas there
ere no significant correlations at high shear (Table 3). Plasma
iscosity itself correlated positively with age (r  0.47, p 
.002) and fibrinogen (r  0.41, p  0.044). By bivariate
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July 18, 2006:356–65 Viscosity and Iron Deficiency in Cyanosisegression, the only predictor of plasma viscosity was age (r 
.54, p  0.007), and not fibrinogen.
elationship of symptoms to viscosity and iron deficiency.
otal viscosity symptom scores ranged from 3 to 20 and
ere normally distributed (mean 9.8  4.3, median 9.5).
ecause questions to patients with developmental delay (n
) were usually answered by the parents or caregiver, these
atients were initially excluded from this portion of the
nalysis. Fatigue was ranked highest (mean 1.95  1.0),
ccounting for 19% of the total points scored. Headache and
aintness/dizziness were also common, and each accounted
or 12%. Epistaxis, gingival bleeding, and gout were the
east common, each contributing only 5% of total points.
iscosity symptom score did not correlate with age, oxygen
aturation, Hb, Hct, MCV, MCH, ferritin, Tsat, or whole
lood viscosity at any shear rate. We found no association
etween symptom score and the use of any specific medi-
ation, nor with exercise capacity (peak VO2 or exercise
uration). However, there was a positive correlation be-
ween total score and Hct-adjusted viscosity at all shear rates
etween 4.39 s1 and 128.5 s1 (r 0.37, p 0.02, and r
Table 1. Comparisons Between Iron-Replete a
Ir
General
Age (yrs) 3
Female gender (n)
Developmental delay (n)
New York Heart Association
functional class III to IV (n)
Total viscosity symptom score 1
Heart rate (beats/min)
Resting O2 saturation (%)
Factors related to iron deficiency
Current iron supplementation (n)
Hemoptysis within 1 yr (n)
Phlebotomy within 1 yr (n)
Menorrhagia (n)*
Any risk factor†
1 risk factor†
Hematology
Hemoglobin (g/dl) 2
Hematocrit (spun, %)
Packed cell volume (%)
RBC count (109/l)
MCV (fl)
MCH (g)
MCHC (g/dl) 3
Biochemistry
Fibrinogen (g/l)
Serum iron (mol/l)
Total iron-binding capacity (mol/l)
Transferrin (g/l)
Transferrin saturation (%)
Ferritin (g/l)
P50 of O2-Hb curve (mm Hg) 2
Results expressed as mean SD for normal continuous variab
or frequencies (%) for binary variables. *Menorrhagia percent
phlebotomy within the last year, or menorrhagia.
O2-Hb  oxygen-hemoglobin dissociation; MCH 
hemoglobin concentration; MCV  mean corpuscular volum.41, p  0.01, respectively). pUsing a symptom score cutoff of above or below the
edian (10 vs. 10), two groups were defined and
ompared. No difference was found in whole blood viscosity.
owever, there was a significantly higher Hct-adjusted viscos-
ty in those with higher symptom score (n 14) for shear rates
.74 s1 to 128.5 s1 (p  0.05 for each) (Fig. 3).
xercise capacity. Thirty-five patients completed a 6-min
alk test. No significant differences in walk distance were
bserved between patients with and without iron defi-
iency, and there was no correlation between any viscosity
easurement and distance walked, heart rate attained, or
ecrease in oxygen saturation from baseline. Twenty-
hree patients completed a treadmill exercise study with
O2. Reasons for nonparticipation were orthopedic lim-
tations, difficulty with instructions regarding the mouth-
iece, patient unwillingness, or logistical problems with
quipment availability on the study day. No differences
ere found between those who did and did not exercise.
he iron-deficient (n  8) and iron-replete (n  15)
roups did not differ with respect to treadmill exercise
uration, decrease in oxygen saturation at peak exercise,
on-Deficient Patients
eplete Iron-Deficient p Value
25 n  14
13.1 40.0  13.0 0.63
6%) 9 (64%) 0.48
4%) 3 (21%) 1.00
6%) 5 (36%) 1.00
3.7 9.0  5.4 0.42
17 85  15 0.95
7 76  7 0.019
6%) 3 (21%) 0.69
8%) 7 (50%) 0.29
%) 5 (36%) 0.075
1%) 4 (44%) 0.40
8%) 11 (79%) 0.063
%) 4 (29%) 0.047
2.5 18.5  2.8 0.021
9 64  10 0.99
8 61  9 0.84
.73 7.40/4.41 0.017
7 81  9 0.001
.4 25.7/8.2 0.001
1.5 30.1  1.3 0.001
1.5 2.8  0.6 0.095
5.0 7.9/6.2 0.001
15 79  18 0.005
0.5 3.3  0.6 0.001
0 9/9 0.001
4 7/10 0.001
2.1 31.1  2.8 0.021
ean/interquartile range for non-normal continuous variables,
of female patients only. †Risk factors include hemoptysis or
corpuscular hemoglobin; MCHC  mean corpuscular
C  red blood cell.nd Ir
on-R
n 
7.8 
19 (7
6 (2
9 (3
0.3 
85 
82 
4 (1
7 (2
2 (8
4 (2
12 (4
1 (4
0.6 
64 
62 
6.16/1
95 
30.5/3
2.3 
3.8 
22.5/1
63 
2.6 
33/2
39/5
8.5 
les, m
age iseak heart rate, or peak VO2.
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Viscosity and Iron Deficiency in Cyanosis July 18, 2006:356–65On univariate regression analysis, no significant correla-
ions were found with exercise parameters and age, oxygen
aturation, MCV, MCH, ferritin, or Hct-adjusted viscosity.
xercise duration correlated with Hct (r  0.42, p 
.047), but not significantly with Hb (r  0.39, p  0.097).
eak VO2 correlated with Hct (r  0.54, p  0.008), Hb
r  0.46, p  0.026), whole blood viscosity at low shear
r  0.42, p  0.044), and plasma viscosity (r  0.51, p 
.014). In bivariate regression analyses, Hct remained the
nly predictor of peak VO2 in models that incorporated Hct
nd either Hb or whole blood viscosity at low shear (partial
 0.54, p  0.0083 for both). In a model including Hct
nd plasma viscosity, both parameters remained indepen-
ently predictive of peak VO2.
Two groups were subsequently defined by a Hct above or
elow 65%, a common cut point for symptom generation
Table 2. Viscosity Data Compared Between Ir
Ir
Whole blood viscosity (mPa·s)
Shear rate  0.27 s1
Shear rate  0.69 s1
Shear rate  1.74 s1
Shear rate  4.39 s1
Shear rate  11.02 s1
Shear rate  27.7 s1
Shear rate  69.5 s1
Shear rate  128.5 s1
Hematocrit-adjusted viscosity (mPa·s)
Shear rate  0.27 s1 4
Shear rate  0.69 s1 3
Shear rate  1.74 s1 2
Shear rate  4.39 s1 1
Shear rate  11.02 s1
Shear rate  27.7 s1
Shear rate  69.5 s1
Shear rate  128.5 s1
Other viscosity parameters
Plasma viscosity (mPa·s)
Red cell aggregation index, low shear 1
Red cell aggregation index, stasis
Results expressed as mean  SD for normal variables or me
able 3. Univariate Correlations for Determinants of Whole Bloo
iscosity)
Variable
Whole Blood Viscos
Low Shear
r Value p Value r Valu
ge (yrs) 0.03 ns 0.0
esting heart rate (beats/min) 0.19 ns 0.1
xygen saturation (%) 0.20 ns 0.0
ematocrit (%) 0.63 <0.001 0.8
acked cell volume (%) 0.52 0.001 0.7
emoglobin (g/dl) 0.47 0.002 0.7
ed blood cell count (109/l) 0.48 0.002 0.5
erritin (g/l) 0.20 ns 0.0
ransferrin saturation (%) 0.54 ns 0.1
ibrinogen (g/l) 0.21 ns 0.2
lasma viscosity 0.17 ns 0.1old indicates that the variable was a significant predictor by bivariate or multiple regressi20,21) (mean for the study population was 64.3%). Those
ith Hct 65% (n  10) had a significantly longer exercise
uration (6.8  1.6 min vs. 4.8  1.7 min, p  0.01) and
eak VO2 (12.6  3.4 ml/kg/m
2 vs. 9.8  2.6 ml/kg/m2,
 0.036) than those with Hct 65% (n  13, Fig. 4).
here was a similar trend for 6-min walk test distance, but
his did not reach statistical significance (401  97 m vs.
32  129 m, p  0.09). In these same individuals, whole
lood viscosity was significantly higher (p  0.003 at all
hear rates) (Fig. 4).
ISCUSSION
rincipal findings. We show that iron deficiency and
icrocytosis do not increase whole blood viscosity in
dults with cyanotic congenital heart disease. Hypervis-
eplete and Iron-Deficient Patients
eplete Iron-Deficient p Value
25) (n  14)
75 134/101 0.59
41 80/55 0.61
26 46.5/30 0.71
15.7 27.6/16.3 1.00
8.9 18.5/10.6 1.00
6.9 12.5/6.0 0.48
5.4 9.4/4.4 0.50
4.8 7.8/3.7 0.44
9.9 48.6  11.5 0.71
5.9 30.5  6.6 0.41
3.6 18.6  4.1 0.26
2.4 11.6  2.8 0.15
2.7 8.1/1.6 0.48
1.4 5.9/1.5 0.15
1.1 4.7/1.0 0.06
0.9 4.0/1.0 0.07
0.2 1.4  0.2 0.68
2.2 9.7  2.8 0.01
0.9 3.1  1.4 0.25
erquartile range for non-normal variables.
iscosity and Viscosity at Hematocrit of 45% (Hct-Adjusted
Hct-Adjusted Viscosity
Shear Low Shear High Shear
p Value r Value p Value r Value p value
ns 0.28 0.09 0.05 NS
ns 0.28 0.10 0.05 NS
ns 0.20 ns 0.10 NS
<0.001 0.09 ns 0.17 NS
0.001 0.07 ns 0.14 NS
0.001 0.12 ns 0.13 NS
0.001 0.12 ns 0.16 NS
ns 0.02 ns 0.15 NS
ns 0.04 ns 0.26 NS
ns 0.27 ns 0.28 NS
ns 0.38 0.02 0.16 NSon-R
on-R
(n 
95/
64/
39/
23.1/
15.2/
11.3/
9.1/
8.2/
9.9 
2.2 
0.1 
2.9 
8.5/
6.2/
5.0/
4.3/
1.4 
1.9 
3.5 d V
ity
High
e
7
1
2
4
7
2
8
5
6
8
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July 18, 2006:356–65 Viscosity and Iron Deficiency in Cyanosisosity symptoms were common in our cohort and corre-
ated with Hct-adjusted viscosity but not with iron status,
ct, Hb, or MCV. Moreover, higher Hct levels were
ssociated with better exercise capacity despite higher
iscosity.
ron deficiency and viscosity. The proposed link between
ron deficiency and hyperviscosity is based on studies with
onsiderable differences in subjects and methods that reach
nconsistent conclusions. Comparisons are also difficult
ecause whole blood viscosity cannot be quantified as a
ingle entity. Many studies were conducted in polycythemic
ubjects (8–10), who, unlike cyanotic patients with second-
ry erythrocytosis, have elevated leukocyte and platelet
ounts that contribute significantly to hyperviscosity and
ymptoms (22,23).
Our finding that iron deficiency does not elevate viscosity
s in harmony with the current understanding of erythro-
oiesis and the general determinants of viscosity. Because of
ron’s key role in Hb synthesis, reduced availability of iron
inders erythropoiesis. Because Hct is the strongest deter-
inant of viscosity (5,15), it is logical to suspect that lower
iscosity, rather than higher, will eventually result from
igure 2. Whole blood viscosity strongly correlates with hematocrit (Hct) a
t lower shear rates (C). The same relationship between shear and viscosity
atients (squares). In contrast, mean corpuscular volume had no relationshipimited iron. dThe second most powerful determinant of viscosity is
brinogen via its role in forming temporary bonds that
acilitate RBC aggregation (24). Aggregation is dependent
n Rouleaux formation, which is hindered by microcytosis.
n iron-deficient patients we found significantly lower RBC
ggregation (low shear) and a nonsignificant trend toward
ower fibrinogen levels. Phlebotomy-induced iron deficiency
as been shown to lower fibrinogen levels in select patients
25), lending further support to our finding that iron
eficiency actually decreases RBC aggregation.
We found a significant right-shifted oxygen-Hb dissoci-
tion curve in iron-deficient patients, which is consistent
ith some (26) but not all studies (17). The rightward shift
avors tissue oxygen release in response to decreased sys-
emic oxygen transport. It is unclear whether this shift is
hysiologically advantageous or detrimental (20). Increased
xygen extraction lowers mixed venous oxygen saturation,
hich when shunted right-to-left will in turn lower arterial
aturation, as seen in iron-deficient patients here.
tiology of iron deficiency. Over one-third of our patients
ere iron deficient, which is several fold higher than in the
eneral population (12) and consistent with other published
low shear (A) and high shear (B), with a logarithmic increase in viscosity
 SD) was seen for both iron-deficient patients (circles) and iron-replete
Hct-adjusted viscosity at any shear rate (D). *p  0.001. fl  femtoliters.t bothata (27). We did not show a significant difference in risk
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Viscosity and Iron Deficiency in Cyanosis July 18, 2006:356–65actors for iron deficiency between iron-deficient and iron-
eplete patients (although the study was underpowered to
how such differences) unless more than one risk factor was
resent (Table 1). In 3 iron-deficient patients no risk factors
ere evident. Iron deficiency in this cohort is most likely
ultifactorial because of: 1) consumption of iron through
rythropoiesis; 2) persistent blood loss through normal menses
r imperceptible gastrointestinal bleeding; and 3) limited
ietary intake and/or absorption. Further work on iron metab-
lism in cyanotic heart disease may clarify etiology.
rigin of symptoms. Although symptoms such as fatigue,
eadache, and lightheadedness were common, we did not
how a significant correlation between self-reported symp-
om scores and Hb, Hct, oxygen saturation, whole blood
iscosity, or exercise function. Importantly, symptom score
s we measured here was unrelated to indices of iron status
i.e., MCV, MCH, Tsat, or ferritin). Similar symptoms
ccur when systemic oxygen transport is low (14), support-
ng the overlapping symptomatology between iron defi-
iency and hyperviscosity.
Although symptoms did not correlate with whole blood
iscosity, symptom score was significantly related to Hct-
djusted viscosity (Fig. 3). This is one of the most intriguing
ndings of our study. None of the hematologic or biochem-
cal variables we measured accounted for this. Several other
ossibilities are worth exploring. It should be remembered that
oiseuille assumptions about flow at steady state (Fig. 1) rarely
pply to blood in the highly complex and pulsatile human
irculation. Flow resistance at rest mainly occurs in the arte-
ioles (10 to 20 m in diameter), where viscosity is more
ependent on local RBC interactions such as temporary
brinogen bonding or Rouleaux formation. In contrast, flow
esistance during exercise (hyperemia) occurs at the capillary
evel in patients with hyperviscosity (28). Because erythro-
ytes pass single file through the capillary bed, flow may
igure 3. Viscosity (mean  SD) is plotted against shear rate for patients w
o difference in whole blood viscosity (A), but a significant difference in vis
.05.epend more on membrane flexibility. All of these variables ere potential targets for further investigation into symptom-
tology.
Iron deficiency has been associated with an increased risk
f stroke in cyanotic children (29–31) and adults (32,33).
he theoretical explanation for this is that iron deficiency
aises viscosity and impairs cerebral blood flow. Several
otential confounders must be considered in light of the
ata presented here. First, abnormalities of clotting factors
nown to occur in cyanosis may have coexisted (34,35).
econd, platelet abnormalities may have been present given
hat iron deficiency is associated with both thrombocytope-
ia (23) and thrombocytosis (36–38). Third, severely cya-
otic patients may have been more aggressively treated with
hlebotomy. Fourth, poor cerebral oxygenation may be
econdary to low Hb levels and reduced systemic oxygen
ransport. Although cerebrovascular events are more com-
on in cyanotic heart disease, event rates are low (39),
aking conclusions based on small cohorts difficult. Al-
hough phlebotomy improves cerebral blood flow, it does
ot increase cerebral oxygen delivery (40) and, as several
nvestigators point out (20,21), it should never be practiced
s a means of reducing stroke risk in these patients regard-
ess of Hct.
ajor determinants of exercise capacity. The predomi-
ant factors determining exercise capacity in this cohort
ere Hct and Hb. Counterintuitively, we found that vis-
osity was positively related to exercise capacity via its
ssociation with higher Hct levels, which is certainly a
onfounder, as the regression analysis showed. This intrigu-
ng finding suggests that erythrocytosis to extreme levels
ay be worth the cost of hyperviscosity, and that some
atients may have found an optimal balance between these
wo opposing forces. Systemic oxygen transport (cardiac
utput multiplied by oxygen content) is determined by Hb
14) and not Hct. To optimize oxygen delivery without
hyperviscosity symptom score 10 compared with those 10. There was
adjusted to a hematocrit (Hct) of 45% at shear rates 4.39 s1 (B). *p ith axacerbating hyperviscosity, one would maximize Hb within
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July 18, 2006:356–65 Viscosity and Iron Deficiency in Cyanosishe smallest volume of Hct. To do so, erythrocytes should
e bigger (i.e., higher MCV) with a higher concentration of
b (i.e., increased MCHC). Macrocytosis in cyanotic heart
isease has been described (26,27). Indeed, 3 of our patients
ere macrocytic (100 femtoliters) (Fig. 2D) without any
vidence of folate or vitamin B12 deficiency, liver disease,
ypothyroidism, reticulocytosis, or Down syndrome (41).
his macrocytic trend may be part of the normal response to
yanosis. Contrarily, iron deficiency lowers Hb, although
ct remains unchanged, as our data show; hence this
ptimal balance is lost. Increasing Hb with iron supplemen-
ation but preserving Hct through phlebotomy has been
hown to improve exercise function (42), although we could
ot show differences in exercise function relative to iron
eficiency in this study.
Exercise performance in cyanotic heart disease is com-
lex, and multiple factors likely each play separate roles in
imiting exertional capacity (43). Because plasma viscosity
as an independent predictor of peak VO2, this may be
igure 4. Exercise and viscosity parameters are compared between patient
ean treadmill exercise duration (A) and higher peak oxygen consumption
D) in the same group. VO2  oxygen consumption; low shear  0.27 s
1; hnother avenue for additional study. Flinical implications. In the clinical care of patients with
yanotic heart disease, the relationship between iron and
yperviscosity is raised in discussions of the appropriateness
f supplemental iron and the indications for therapeutic
hlebotomy. Risk of “decompensated” overproduction, de-
ned as a rapid increase in Hct via raised erythropoietin
evels as soon as any supplemental iron is given (17), has
een used by several investigators as justification to limit
ral iron by treating only until an increase in Hct is
iscernable (20,21). However, those with higher Hct had
etter exercise duration in our data set. Thus it seems
mprudent that any level of Hct should be universally consid-
red too high (20). Iron should be in sufficient supply to allow
ne to attain steady-state erythropoiesis as determined by the
atient’s own unique underlying physiology. It has been shown
hat hyperviscosity can be alleviated with supplemental iron
ithout inducing clinical decompensation (44).
Several findings in our study may be relevant to discus-
ions about the appropriateness of therapeutic phlebotomy.
hematocrit (Hct) 65% or 65%. Those with higher Hct had a longer
) (B) despite higher whole blood viscosity at low shear (C) and high shear
hear  128.5 s1.s withirst, we show that iron deficiency lowers Hb but not Hct
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Viscosity and Iron Deficiency in Cyanosis July 18, 2006:356–65ecause of production of more but smaller RBCs. Thus, one
ould expect long-term phlebotomy to reduce Hb yet have
o lasting effect on Hct and viscosity. Second, patients with
ower Hct had a lower exercise capacity, implying that
educing Hct to improve exercise tolerance may be disad-
antageous. Third, we found that symptoms attributed to
yperviscosity are just as frequent at lower Hct levels, as
ave others (44). Again, such symptoms may also be
ttributable to iron deficiency per se irrespective of Hb level
45), or may relate to poor systemic oxygen delivery. Hence,
lthough this was not a study of therapeutic phlebotomy,
ur findings suggest the practice may be counterproductive.
o our knowledge, no one has yet shown long-term (2
eeks) (46) symptomatic improvement in cyanotic heart
isease from phlebotomy, nor any prognostic advantage.
tudy limitations. Any study of viscosity is bound by the
imits of the simplified steady-state models used to measure
nfinitely more complex and dynamic systems in vivo. Our
tudy focused on a representative range of shear. Others
ave used a similar range (9,47), but this is by no means
xhaustive. The clinical relevance of more extreme rates of
hear becomes questionable.
Sample size limits the power to detect small differences
nd is a limitation of this cross-sectional study. Our sample
ize is adequate to detect a 20% difference in Hct-adjusted
iscosity (low or high shear) with 80% power, whereas
hese values differ by 10% in our data set. We have
nsufficient power to show that the differences we encoun-
ered were different, but we conclude they are not different.
n fact, some trends suggest that iron-deficient patients have
ower Hct-adjusted viscosity (high shear), which reinforces
onfidence in the conclusion that they are indeed not
igher. Although the study is underpowered to show the
ignificance of smaller differences in viscosity, they arguably
ould not be clinically relevant. Despite the fact that not all
atients participated in treadmill exercise testing, the power
n this study to show significantly higher exercise duration
n those with Hct 65% was 83% (one-tailed). Power to
how a higher peak VO2 was only 64%, however. This study
eports on a number of statistical analyses. No special
echnique was used to adjust the p values of individual
omparisons. Because the risk of type I error was 0.05 for
ach, the cumulative risk of there being at least one type I
rror in the study may be large.
The inherent variability in underlying anatomy and phys-
ology in this patient population further challenges the
nalysis of data. Self-reported symptom assessment such as
e used here is subjective and not formally validated. We
sed a symptom score designed specifically with hypervis-
osity in mind (1), but acknowledge the limitations of
aking any conclusion based on this unsubstantiated tool.
e recognize that exercise capacity is dependent on patient
ooperation and motivation. Larger longitudinal studies are
ikely to shed more light on the complex interactions
etween viscosity, iron, symptoms, exercise capacity, and
reatment effects.onclusions. Iron deficiency and microcytosis do not in-
rease blood viscosity in adults with cyanotic congenital
eart disease. Symptoms such as fatigue, headache, and
izziness are common in cyanotic patients, but unrelated to
ct, Hb, iron indices, or cell size. However, these symp-
oms do correlate with higher viscosity when Hct is con-
rolled, although this relationship is unrelated to iron and
erits further investigation. Exercise capacity is greater in
atients with higher Hct despite their higher blood viscos-
ty. More studies on achieving iron equilibrium and optimal
b levels will refine the management of these complex
atients.
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